Previous Article | Next Article ![]()
Infect. Immun., May 1995, 1790-1795, Vol 63, No. 5
T Chen, J Swanson, J Wilson and RJ Belland
The pathobiological significance of lipooligosaccharide (LOS) and outer
membrane opacity protein (Opa) changes in gonorrheal disease are poorly
understood. We assessed variants of strain MS11mk with different LOS and
Opa phenotypes for their liability to killing by normal human sera. LOS
differences correlated with strikingly disparate susceptibilities to serum
killing; LOSa variants were serum resistant, LOSb variants were serum
sensitive, and sialylation of LOSb variants enhanced their survival (as
reported previously). Opa phenotype had little influence on the killing of
serum-sensitive LOSb cells that were incubated directly in normal human
sera, but preincubation of Opa+ LOSb variants in heparin increased their
serum resistance whereas Opa- LOSb variants showed no change. Some Opa
proteins conferred slightly higher resistance than others, but heparin
preincubation increased serum resistance for variants expressing each of
seven Opa proteins. These in vitro phenomena may relate to conditions
within the male urethra where sulfate-containing proteoglycans are abundant
and where antibody and complement may transude from blood plasma. The
results suggest that the selective advantage for Opa+ Neisseria gonorrhoeae
bacteria observed in vivo may reflect their ability to utilize host cell
components to resist killing by host defenses.
Copyright © 1995, American Society for Microbiology
Heparin protects Opa+ Neisseria gonorrhoeae from the bactericidal action of normal human serum
Laboratory of Microbial Structure and Function, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, Hamilton, Montana 59840, USA.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|